跳至主要内容
临床试验/IRCT20200304046692N1
IRCT20200304046692N1已完成未知

Evaluating the Effect of Spirulina Consumption on Anthropometric, Glucose, Lipid, Antioxidant, Inflammatory indices and Liver Enzymes in Non-Alcoholic ?Fatty Liver Patient.

Shiraz University of Medical Sciences0 个研究点目标入组 46 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
已完成
入组人数
46

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
no limit 至 no limit(—)
性别
All

入选标准

  • Individuals with Non-alcoholic fatty liver disease

排除标准

  • Individuals with malnutrition
  • Individuals with alcohol consumption
  • taking lipid-lowering drugs
  • following special diets such as vegetarian or raw vegetarian
  • diseases such as diabetes mellitus, cardiovascular disease, liver disease (cirrhosis, alcoholic liver disease, viral hepatitis, autoimmune hepatitis, primary biliary cirrhosis, biliary obstruction, hepatic injury induced by hereditary hemochromatosis drugs, sclerosis cholangitis, and a antisense deficiency), cancer, renal failure, celiac; being in pregnancy and lactation.
  • taking Drugs that cause fatty liver (methotrexate, tamoxifen, valproate, etc.)

研究者

相似试验